Stocks / Stock overview

Alkami Technology, Inc. (ALKT)

$20.22-0.64%Aft $20.22 (+0.00%)Market cap $2.16B

NasdaqGS · Price as of · Nasdaq Real Time Price

Stock Scorer
B61/100
  • Profitability5/20

    Losing money ($-49.8M over the last four reported quarters), but the top line is growing fast. Revenue over the last four reported quarters was $475.6M, up 31% from $363.1M the year before. Growth this quick earns partial credit; it still has to turn into profit.

  • Insider buying vs selling15/20

    The last 20 Form 4s show no open-market buys or sells (grants and option exercises don't count either way). Neutral. Separately, 3 new 5%+ stake disclosures (13D/13G) hit in the last 6 months, which is big-money accumulation.

  • Dilution and offerings11/15

    Share count up 2.7% in a year. Mild dilution.

See the full breakdown
Analyst consensus
Buy$22.00
  • Analysts7
  • Implied upside+8.8%
  • Target range$19.00 to $25.00
Analyst estimates are opinions, not forecasts of what the stock will do.
Source: Yahoo Finance consensus, retrieved
Next earnings
October 28, 2026after the close
  • EPS expected$0.20 +51%
  • A year ago$0.13
  • Revenue expected$133.5M +18%
  • Estimate range$0.15 to $0.22
Consensus of 8 analysts for the quarter ending September 30, 2026. Beat the estimate in 2 of the last four quarters. Estimates are what Wall Street expects, not our forecast.
Source: Yahoo Finance earnings calendar
ALKT past month+13.5%
ALKT closed at $20.22 on Aug 28, up 13.5% since Jul 30.$20.22$20.78$16.91Jul 30Aug 28
Close 20-day average 50-day average 200-day average

ALKT closed at $20.22 on Aug 28, up 13.5% since Jul 30. Chart read: price above both the 50-day and 200-day moving averages; the 50-day is below the 200-day (downtrend structure); trading at 47% of the 52-week range ($14.59 to $26.53).

Insider buying and selling at Alkami Technology, Inc. (ALKT)

Source: SEC Form 4 filingsLatest filed

The most recent Form 4 on record for Alkami Technology, Inc. (ALKT) is May 12, 2026, when Atlantic Genpar (BERMUDA), L.p. General, Director, bought $32.9M of stock. An open-market purchase is money the filer chose to put in.

InsiderActionValueDateType
Atlantic Genpar (BERMUDA), L.p. General · DirectorBuy$32.9MMay 12, 2026Own call
Atlantic Genpar (BERMUDA), L.p. General · DirectorBuy$34.7MMay 4, 2026Own call
ATLANTIC, L.p. General · DirectorBuy$34.7MMay 4, 2026Own call
Atlantic Genpar (BERMUDA), L.p. General · DirectorBuy$50.6MMarch 9, 2026Own call
ATLANTIC, L.p. General · DirectorBuy$50.6MMarch 9, 2026Own call
Alex Shootman · Chief Executive OfficerSell$941,026December 9, 2025Tax withholding
Alex Shootman · Chief Executive OfficerSell$1.1MSeptember 9, 2025Tax withholding
W Bryan Hill · Chief Financial OfficerSell$504,262September 2, 2025Tax withholding
All insider activity

SEC filings

Source: SEC EDGARLatest filed

FormFiledDescription
SCHEDULE 13G/AAugust 14, 2026View on EDGAR
4August 11, 2026FORM 4
10-QJuly 30, 202610-Q
8-KJuly 29, 20268-K
4July 7, 2026FORM 4
4July 7, 2026FORM 4
4July 7, 2026FORM 4
4July 7, 2026FORM 4
All SEC filings

Frequently asked questions

When does ALKT report earnings?

Alkami Technology, Inc. (ALKT) is scheduled to report quarterly results on October 28, 2026, after the close. The 8-analyst consensus is $0.20 per share on revenue of $133.5M for the quarter ending September 30, 2026, against $0.13 and $113.0M a year earlier. It has beaten the consensus EPS estimate in 2 of the last four quarters.

What do analysts expect for ALKT?

7 analysts cover Alkami Technology, Inc. (ALKT). The consensus rating is Buy. The average price target is $22.00, in a range of $19.00 to $25.00.

Are insiders buying or selling ALKT?

We track Form 4 filings for Alkami Technology, Inc. (ALKT). The activity listed on this page shows 5 open-market purchases and 4 qualifying sales. Each row is labelled Routine when the filer declared a pre-arranged 10b5-1 plan, Tax withholding when shares were sold automatically to cover the tax on a vest, or Own call when neither applies.

Where can I see ALKT SEC filings?

Recent filings are listed on this page, newest first. The latest is a SCHEDULE 13G/A filed August 14, 2026.

Data on this page comes from SEC EDGAR, public disclosure feeds and market data providers, and may be delayed or incomplete. Nothing here is investment advice.